Advertisement

Klinisch-pharmakologische Grundlagen der Schmerztherapie insbesondere des Neugeborenenalters

  • B. Roth
  • Ch. Hünseler

Zusammenfassung

Nozizeption ist bereits ab der 20.–22. Schwangerschaftswoche (SSW) möglich. Kortikale Schmerzverarbeitung geschieht ab der 24. Schwangerschaftswoche [216]. Dabei ist bei Früh- und Neugeborenen das zentrale Schmerzhemmungssystem deutlich schlechter ausgebildet als das nozizeptive System, sodass beim Früh- und Neugeborenen generell vom Überwiegen nozizeptiven Stresses auszugehen ist.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. 1.
    Adam D, Stankov G (1994) Treatment of fever in childhood. Eur J Pediatr 153: 394–402CrossRefPubMedGoogle Scholar
  2. 2.
    Adelmann C, Kribs A, Keuth B, Licht C, Roth B (1998) Doppelblinder, randominiserter Vergleich von Sufentanil und Fentanyl in der Analgosedierung beatmeter reifer Neugeborener mit schwerem Lungenversagen. Z. Geburtshilfe Neonat. 201 (S1): 9Google Scholar
  3. 3.
    Anand KJS, Hickey PR (1987) Pain and its effects in the human neonate and fetus. N Engl J Med 317: 1321–1329CrossRefPubMedGoogle Scholar
  4. 4.
    Anand KJS, Arnold JH (1994) Opioid tolerance and dependence in infants and children. Crit Care Med 22: 334–342CrossRefPubMedGoogle Scholar
  5. 5.
    Anand KJS, Mc Intosh N, Lagercrantz H, Pelausa E, Young TE, Vasa R (1999) Analgesia and sedation in preterm Neonates who require ventilatory support. Arch Pediatr Adolesc Med 153: 331–338CrossRefPubMedGoogle Scholar
  6. 6.
    Anderson BJ, Holford NHG (1997) Rectal paracetamol dosing regimes: determination by computer simulation. Paediatr Anaesth 7: 451–455CrossRefPubMedGoogle Scholar
  7. 7.
    Aranda JV, Varvarigou A, Beharry K, Bansal R, Bardin C, Modanlou H, Papageorgiou A, Chemtob S (1997) Pharmacokinetics and protein binding of intravenous ibuprofen in the premature newborn infant. Acta Paediatr 86: 289–293CrossRefPubMedGoogle Scholar
  8. 8.
    Arnold JH, Truog RD, Orav EJ, Scavone JM, Hershenon MB (1990) Tolerance and dependence in neonates sedated with fentanyl during extracorporal membrane oxygenation. Anesthesiology 73: 1136–1140CrossRefPubMedGoogle Scholar
  9. 9.
    Arnold JH, Truog RD, Scavone JM, Fenton I (1991) Changes in the pharmacodynamic response to fentanyl in neonates during continuous infusion. J Pediatr 119: 639–643CrossRefPubMedGoogle Scholar
  10. 10.
    Arnold JH, Truog RD (1992) Sedation in neonatal and pediatric intensive care. J Intens Care Med 7: 244–260Google Scholar
  11. 11.
    Atwood GF, Evans MA, Harbinson RD (1976) Pharmacokinetics of meperidine in infants. Pediatr Res 10: 328Google Scholar
  12. 12.
    Ball M, Moore RA, Fisher A, McQnay HJ, Allen MC, Seas J (1985) Renal failure and the use of morphine in intensive care. Lancet 1:784–786CrossRefPubMedGoogle Scholar
  13. 13.
    Balogh A, Melzer K, Ziehl U, Finke G, Voigt L, Hoffmann A (1989) Elimination von Metamizol (Analgin) — Metaboliten im Kindesalter. Z Klin Med 44: 213–215Google Scholar
  14. 14.
    Band CJ, Band PR, Deschamps M (1994) Human pharmacokinetic study of immediaterelease (codeine phosphate) and sustained-release (codeine Contin) codeine. J Clin Pharmacol 34: 938–943CrossRefPubMedGoogle Scholar
  15. 15.
    Banos JE, Barajas C, Martin, ML et al. (1999) A survey of postoperative pain treatment in children of 3–14 years. Eur J Pain 3: 275–82CrossRefPubMedGoogle Scholar
  16. 16.
    Barker DP, Simpson J, Pawula M et al. (1995) Randomised, double blind trial of two loading dose regimes of diamorphine in ventilated newborn infants. Arch Dis Child 73: F22–F26CrossRefGoogle Scholar
  17. 17.
    Barrett DA, Elias-Jones AC, Rutter N, Shaw PN, Davis SS (1991) Morphine kinetics after diamorphine infusion in premature neonates. Br J Clin Pharmacol 32: 31–37CrossRefPubMedGoogle Scholar
  18. 18.
    Baumert J (2000) Remifentanil in der Kinderanästhesie. 18. Internationales Aachener Anästhesie-Symposium (Vortrag). Aachen: März 2000Google Scholar
  19. 19.
    Bentley JB, Borel JA, Nenad RE, Gillespie TJ (1982) Age and fentanyl kinetics. Anesth Analg 61: 968–971CrossRefPubMedGoogle Scholar
  20. 20.
    Berde CB, Beyer JE, Bournaki M-C, Levin CR, Sethna NF (1991) Comparison of morphine and methadone for prevention of postoperative pain in 3- to 7-year-old children. Pediatr 119: 136–141CrossRefGoogle Scholar
  21. 21.
    Bhat R, Ghari G, Gulati A, Aldana O, Velamati R, Bhargava R (1990) Pharmacokinetics of a single dose of morphine in preterm infants during the first week of life. J Pediatr 117: 477–481CrossRefPubMedGoogle Scholar
  22. 22.
    Birmingham PK, Tobin MJ, Henthorn TK et al. (1997) Twenty-four-hour pharmacokinetics of rectal acetaminophen in children. Anesthesiology 87: 244–252CrossRefPubMedGoogle Scholar
  23. 23.
    Bjorkman R, Hallman KM, Hedner J, Hedner T, Henning H (1994) Acetaminophen blocks spinal hyperalgesia induced by NMDA and substance P. Pain 57: 259–264CrossRefPubMedGoogle Scholar
  24. 24.
    Boas RA, Vilhinger JW (1985) Clinical actions of fentanyl and buprenorphin. The significance of receptor binding. Br J Anaesth 57: 192–196CrossRefPubMedGoogle Scholar
  25. 25.
    Bovill JG, Sebel PS, Blackburn CL et al. (1984) The pharmacokinetics of sufentanil in surgical patients. Anesthesiology 61: 502–506CrossRefPubMedGoogle Scholar
  26. 26.
    Bovill JG (1987) Which potent opioid? Important criteria for selection. Drugs 33: 520–530CrossRefPubMedGoogle Scholar
  27. 27.
    Bullingham RES, Mc Quay HJ, Moore A, Martin R, Bemiet D (1980) Buprenorphine kinetics. Clin Pharmacol Ther 28: 667–672CrossRefPubMedGoogle Scholar
  28. 28.
    Bullingham RES, Mc Quay HJ, Porter EJB, Mc Allen C, Moore RA (1982) Sublingual buprenorphin used postoperatively: ten hour plasma drug concentration analysis. Br J Clin Pharmacol 13: 665–73CrossRefPubMedGoogle Scholar
  29. 29.
    Bullingham RES, Mc Quay H, Moore RA (1983) Clinical pharmacokinetics of narcotic agonist-antagonist drugs. Clin Pharmacokin 8: 332–343CrossRefGoogle Scholar
  30. 30.
    Burtin P, Daoud P, Jacqz-Aigrain E, Mussat P, Moniette G (1991) Hypotension with midazolam and fentanyl in the newborn. Lancet 337: 1545–1546CrossRefPubMedGoogle Scholar
  31. 31.
    Caldwell J, Notarianni LJ, Smith RL (1978a) Impaired metabolism of pethidin in the human neonate. Br J Clin Pharm 5: 362–363Google Scholar
  32. 32.
    Caldwell J, Wahile LA, Notariaumi LJ et al. (1978b) Maternal and neonatal disposition of pethidin in childbirth — a study using quantitative gas chromatography — mass spectrometry. Life Sci 22: 589–96CrossRefPubMedGoogle Scholar
  33. 33.
    Chay P W, Duffy BJ, Walker JS (1992) Pharmacokinetic-pharmacodynamic relationships of morphine in neonates. Clin Pharmacol Ther 51: 334–342CrossRefPubMedGoogle Scholar
  34. 34.
    Chauvin M, Ferrier C, Haberer JP, Spielvogel C, Lebrault L, Levron IL, Deuvoldestin P (1989) Sufentanil pharmacokinetics in patients with cirrhosis. Anesth Analg 68: 1–4CrossRefPubMedGoogle Scholar
  35. 35.
    Choonara I, Ekbom Y, Lindström B, Raue A (1990) Morphine sulphatation in children. Br J Clin Pharmacol 30: 897–900CrossRefPubMedGoogle Scholar
  36. 36.
    Collins C, Koren G, Crean P, Klein J, Roy WL, Laclerc SM (1985) Fentanyl pharmacokinetics and hemodynamic effects in preterm infants during ligation of patent ductus arteriosus. Anesth Analg 64: 1078–1080CrossRefPubMedGoogle Scholar
  37. 37.
    Crofford LJ (1997) Cox-1 and Cox-2 tissue expression: Implications and predictions. J Rheumatol 24 (S49): 15–19Google Scholar
  38. 38.
    Dagan O, Klein J, Bohn D, Barker G, Kosen G (1993) Morphine pharmacokinetics in children following cardiac surgery: Effects of disease and inotropic support. Cardiothor Vasc Anesth 7: 396–398CrossRefGoogle Scholar
  39. 39.
    Dahlström B, Bolme P, Feychting H, Hoack G, Paalzow L (1979) Morphine kinetics in children. Clin Pharmacol Ther 26: 354–365PubMedGoogle Scholar
  40. 40.
    Davies G, Kingswood C, Street M (1996) Pharmacokinetics of opioids in renal dysfunction. Clin Pharmacokinet 31: 410–422CrossRefPubMedGoogle Scholar
  41. 41.
    Davis PJ, Cook DR, Stiller RL, Davis-Robinson KA (1987) Pharmacodynamics and pharmacokinetics of high-dose sufentanil in infants and children undergoing cardiac surgery. Anesth Analg 66: 203–208CrossRefPubMedGoogle Scholar
  42. 42.
    Davis PJ, Stiller RL, Cook DR, Brandow BW, Robinson KAD (1988) Pharmacokinetics of sufentanil in adolescent patients with chronic renal failure. Anesth Analg 67: 268–271PubMedGoogle Scholar
  43. 43.
    Davis PJ, Stiller RL, Cook DR, Brandom BW, Davis IE, Scierka AM (1989a) Effects of cholestatic hepatic disease and chronic renal failure on alfentanil pharmacokinetics in children. Anesth Analg 68 68: 579–583PubMedGoogle Scholar
  44. 44.
    Davis PJ, Killian A, Stiller RL, Brandner BW, Davis JE, Scierka AM (1989b) Pharmacokinetics of alfentanil in newborn premature infants and older children. Dev Pharmacol Ther 13: 21–27PubMedGoogle Scholar
  45. 45.
    Davis PJ, Ross A, Stiller RL, Muir K, McYowan FX, Gupta SK, Margolis J, Greely WJ (1995) Pharmacokinetics of remifentanil in anesthetized children 2–12 years of age. Anesth Analg 80: S93CrossRefGoogle Scholar
  46. 46.
    Davis PJ, Ross AK, Henson LG, Muir KT (1997a) Remifentanil pharmacokinetics in neonates. Anesthesiology 87: A1064CrossRefGoogle Scholar
  47. 47.
    Davis PJ, Lermon J, Sunesh S et al. (1997b) A randomized multicenter study of remifentanil compared with alfentanil, isoflurane, or propofol in anesthetized pediatric patients undergoing elective strabismus surgery. Anesth Analg 84: 982–989PubMedGoogle Scholar
  48. 48.
    De Souza G, Lewis MC, Ter Riet MF (1997) Severe bradycardia after remifentanil. Anesthesiology 87: 1019–1020CrossRefGoogle Scholar
  49. 49.
    Delbos A, Boccard E (1995) The morphine sparing effect of propacetamol in orthopedic postoperative pain. J Pain Symptom Manage 10: 279–232CrossRefPubMedGoogle Scholar
  50. 50.
    Den Hollander JM, Hennies PJ, Burm AG, Bovill JG (1988) Alfentanil in infants and children with congenital heart defects. J Cardiothorac Anesth 2: 12–17CrossRefGoogle Scholar
  51. 51.
    Den Hollander JM, Hennis PJ, Burm AG, Vletter AA, Bovill JG (1992) Pharmacokinetics of alfentanil before and after cardiopulmonary bypass in pediatric patients undergoing cardiac surgery Part I. J Cardiothorac Vasc Anesth 6: 308–312CrossRefGoogle Scholar
  52. 52.
    Dershwitz M, Rosow CE, Michalowski P, Connors PM, Hoke JF, Muir KT, Dienstag JL (1994) Pharmacokinetics and pharmacodynamics of remifentanil in volunteer subjects with severe liver disease compared with normal subjects. Anesthesiology 81: A377CrossRefGoogle Scholar
  53. 53.
    Dewey WL (1984) Various factors which affect the rate of development of tolerance and physical dependence to abused drugs. NIDA Res Monogr 54: 39–49PubMedGoogle Scholar
  54. 54.
    Dickenson AH (1995) Spinal cord pharmacology of pain. Br J Anaesth 75: 193–200CrossRefPubMedGoogle Scholar
  55. 55.
    Don Brown R, Wilson JT, Kearns GL, Eichler VF, Johnson VA, Bertrand KM (1992) Single-dose pharmacokinetics of ibuprofen and acetaminophen in febrile children. J Clin Pharmacol 32: 231–241CrossRefPubMedGoogle Scholar
  56. 56.
    Egan TD, Lemmens HJM, Fiset P, Herman DJ, Muir KT, Stanski DR, Shater SL (1993) The pharmacokinetics of the new short-acting opioid remifentanil (GI 87084B) in healthy adult male volunteers. Anesthesiology 79: 881–892CrossRefPubMedGoogle Scholar
  57. 57.
    Egan TD (1995) Remifentanil pharmacokinetics and pharmacodynamics — a preliminary appraisal. Clin Pharmacokinet 29: 80–94CrossRefPubMedGoogle Scholar
  58. 58.
    Ehrnebo M, Boreus LO, Lönroth U (1977) Bioavailability and first-pass metabolism of oral pentazocine in man. Clin Pharmacol Ther 22: 888–892PubMedGoogle Scholar
  59. 59.
    Elias-Jones AC, Barrett DA, Rutter N, Shaw PN, Davis SS (1991) Diamorphine infusion in the preterm neonate. Arch Dis Child 66: 1155–1157CrossRefPubMedGoogle Scholar
  60. 60.
    Ferrier C, Marty J, Baufford N, Haberer Levron JC, Duvaldestin P (1985) Alfentanil pharmacokinetics in patients with cirrhosis. Anesthesiology 62: 480–484CrossRefPubMedGoogle Scholar
  61. 61.
    Fitzgerald M, Koltzenburg M (1986) The functional development of descending inhibitory pathways in the dorsolateral funiculus of the newborn rat spinal cord. Dev Brain Res 24: 261–270CrossRefGoogle Scholar
  62. 62.
    Fitzgerald M, Anand KJS (1993) Developmental neuroanatomy and neurophysiology of pain. In: Schechter NL, Berde CB, Yaster M (eds) Pain in infants: children and adolescents. Williams &amp Wilkins: Baltimore, pp 11–32Google Scholar
  63. 63.
    Freye E, Azevodo L, Hartung E (1985) Reversal of fentanyl related respiratory depression with nalbuphine: effects on the CO2-response curve in man. Acta Anaesthesiol Belg 36: 365–374PubMedGoogle Scholar
  64. 64.
    Freye E (1989) Theoretische Grundlagen der Opioidanwendung im Neugeborenenund Säuglingsalter. In: Ahnefeld FW, Altemeyer K-H, Försel T, Kraus G-B, Rügheimer E (Hrsg) Anästhesie bei Früh- und Neugeborenen. Springer, Berlin Heidelberg New York Tokio, S 161–170CrossRefGoogle Scholar
  65. 65.
    Franck LS, Miaskowski C (1998) The use of intravenous opioids to provide analgesia in critically ill premature neonates: A research critique. J Pain Symptom Manage 15: 41–69CrossRefPubMedGoogle Scholar
  66. 66.
    Gaudreault P, Guay J, Nicol O, Dupuis K (1988) Pharmacokinetics and clinical efficacy of intrarectal solution of acetaminophen. Can J Anaesth 35: 149–152CrossRefPubMedGoogle Scholar
  67. 67.
    Gauntlett I S, Fisher DM, Hertzka RE, Kuhls E, Spellman MJ, Rudolph C (1988) Pharmacokinetics of fentanyl in neonatal humans and lambs: effects of age. Anesthesiology 69: 683–687CrossRefPubMedGoogle Scholar
  68. 68.
    Glare PA, Walsh TD (1991) Clinical pharmacokinetics of morphine. Ther Drug Monit 13: 1–23CrossRefPubMedGoogle Scholar
  69. 69.
    Gourlay GK, Kowalski SR, Plummer JL, Constins MJ, Armstrong PJ (1988) Fentanyl blood concentration-analgesic response relationship in the treatment of postoperative pain. Anesth Analg 67: 329–337CrossRefPubMedGoogle Scholar
  70. 70.
    Goresky GV, Koren G, Sabourin MA, Sale JP, Strunin L (1987) The pharmacokinetics of alfentanil in children. Anesthesiology 67: 654–659CrossRefPubMedGoogle Scholar
  71. 71.
    Greely WJ, de Bruijn NP, Davis DP (1987) Sufentanil pharmacokinetics in pediatric cardiovascular patients. Anesth Analg 66: 1067–1072Google Scholar
  72. 72.
    Greely WJ, de Bruijn NP (1988) Changes in sufentanil pharmacokinetics within the neonatal period. Anesth Analg 67: 86–90CrossRefGoogle Scholar
  73. 73.
    Grießinger N, Rösch W, Schott G, Sittl R (1997) Tramadol-Infusion zur Schmerztherapie nach großen Blaseneingriffen auf Kinderstationen. Urologe 36: 552–556CrossRefPubMedGoogle Scholar
  74. 74.
    Guay J, Gaudreault P, Tang A, Goulet B, Varin F (1992) Pharmacokinetics of sufentanil in normal children. Can J Anaesth 39: 14–20CrossRefPubMedGoogle Scholar
  75. 75.
    Gust R, Böhrer H (1995) Stiff-man syndrome associated with continous sufentanil administration. Anaesthesia 50: 575CrossRefPubMedGoogle Scholar
  76. 76.
    Hamunen K, Maunuksela E-L, Seppälä T, Olkkola KT (1993) Pharmacokinetics of i.v. and rectal pethidin in children undergoing ophthalmic surgery. Br J Anaesth 71: 823–826CrossRefPubMedGoogle Scholar
  77. 77.
    Hamunen K, Olkkola KT, Seppäla T, Lusa G, Maunuksela E-L (1993) Ventilatory effects and kinetics of intravenous pentazocine in children. Pharmacol Toxicol 73: 120–123CrossRefPubMedGoogle Scholar
  78. 78.
    Hamunen K, Olkkola KT, Maunuksela E-L (1993) Comparison of ventilatory effects of morphine and buprenorphin in children. Acta Anaesthesiol Scand 37: 449–453CrossRefPubMedGoogle Scholar
  79. 79.
    Hartley R, Green M, Quinn M, Levene MI (1993) Pharmacokinetics of morphine infusion in premature neonates. Arch Dis Child 69: 55–58CrossRefPubMedGoogle Scholar
  80. 80.
    Hartley R, Green M, Quinn MW, Rushforth JA, Levene MI (1994) Development of morphine glucuronidation in premature neonates. Biol Neonate 66: 1–9CrossRefPubMedGoogle Scholar
  81. 81.
    Hasselström J, Säwe J (1993) Morphine pharmacokinetics and metabolism in humans: enterohepatic cycling and relative contribution of metabolites to active opioid concentrations. Clin Pharmacokin 24: 344–354CrossRefGoogle Scholar
  82. 82.
    Haynes G, Braken NH, Hill HF (1993) Plasma sufentanil concentration after intranasal administration to paediatric outpatients. Can J Anaesth 40: 286CrossRefPubMedGoogle Scholar
  83. 83.
    Hertzka RE, Gauntlett IS, Fisher DM, Spellman MJ (1989) Fentanyl-induced ventilatory depression: effects of age. Anesthesiology 70: 213–218CrossRefPubMedGoogle Scholar
  84. 84.
    Heubi JE, Bien JP (1997) Acetaminophen use in children: More is not better. J Pediatr 130: 175–177PubMedGoogle Scholar
  85. 85.
    Hickey PR, Hanse DD, Klessel DL, Lang P, Jonas RA, Elieson EM (1985) Blunting of stress responses in the pulmonary circulation of infants by fentanyl. Anesth Analg 64: 1137–1142PubMedGoogle Scholar
  86. 86.
    Hoke JF, Shlugman D, Dershwitz M et al. (1997) Pharmacokinetics and Pharmacodynamics of remifentanil in persons with renal failure compared with healthy volunteers. Anesthesiology 87: 533–541CrossRefPubMedGoogle Scholar
  87. 87.
    Hopkins CS, Underhill S, Booker PD (1990) Pharmacokinetics of paracetamol after cardiac surgery. Arch Dis Child 65: 971–976CrossRefPubMedGoogle Scholar
  88. 88.
    Howard CR, Howard FM, Weitzman ML (1994) Acetaminophen analgesia in neonatal circumcision: The effect of pain. Pediatrics 93: 641–46PubMedGoogle Scholar
  89. 89.
    Howie MB, Smith DF, Harrington K et al. (1984) Serum concentrations of sufentanil and fentanyl in the post-operative course in cardiac surgery patients. Anesthesiology 61: A131CrossRefGoogle Scholar
  90. 90.
    Hughes MA, Glass PS A, Jacobs JR (1992) Context-sensitive half-time in multicompartment pharmacokinetic models for intravenous anesthetic drugs. Anesthesiology 76: 334–341CrossRefPubMedGoogle Scholar
  91. 91.
    Iisalo EUM, Iisalo E (1978) A comparison of high dose pentazocine with pethidin and diazepam in paediatric premedication. Ann Chir Gynecol 67: 123–128Google Scholar
  92. 92.
    Jacqz-Aigrain E, Burtin P (1996) Clinical pharmacokinetics of sedatives in neonates. Clin Pharmacokinet 31: 423–443CrossRefPubMedGoogle Scholar
  93. 93.
    Jarvis AP, Arancibia CU (1987) A case of difficult neonatal ventilation. Anesth Analg 66: 196CrossRefPubMedGoogle Scholar
  94. 94.
    Johnson KL, Erickson JP, Holley FO, Scott JC (1984) Fentanyl pharmacokinetics in the pediatric population. Anesthesiology 61: A441CrossRefGoogle Scholar
  95. 95.
    Jorch G, Rickers E, Rabe H, Bömelburg T, Hentschel R, Michel E (1989) Pethidin-Analgesie und Hirnkreislauf bei sehr kleinen Frühgeborenen. Klin Pädiatr 201: 195–198CrossRefPubMedGoogle Scholar
  96. 96.
    Kart T, Chirstrup LL, Rasmussen M (1997) Recommended use of morphine in neonates, infants and children based on a literature review. Part 1: Pharmacokinetics. Pediatr Anaesth 7: 5–11CrossRefGoogle Scholar
  97. 97.
    Kart T, Christrup LL, Rasmussen M (1997) Recommended use of morphine in neonates, infants and children bassed on a literature review. Part 2: Clinical use. Paediatr Anaesth 7: 93–101CrossRefPubMedGoogle Scholar
  98. 98.
    Katz R, Kelley W (1993) Pharmacokinetics of continous infusions of fentanyl in critically ill children. Crit Care Med 21: 995–1000CrossRefPubMedGoogle Scholar
  99. 99.
    Katz R, Kelley HW, Hsi A (1994) Prospective study of the occurrence of withdrawal in critically ill children who receive fentanyl by continous infusion. Crit Care Med 22: 763–767CrossRefPubMedGoogle Scholar
  100. 100.
    Kay B (1980) A double-blind comparison between fentanyl and buprenorphin in analgesic-supplemented anaesthesia. Br J Anaesth 52: 453–457CrossRefPubMedGoogle Scholar
  101. 101.
    Kaltenbach ML, Mohammed SS, Mullersman G, Perrin JH, Derendorf H (1994) Pharmacokinetic evaluation of two ibuprofen-codeine combinations. Int J Clin Pharm Ther 32: 210–214Google Scholar
  102. 102.
    Kamei J (1998) Role of opioidergic and serotonergic mechanisms in cough and antitussives. Pulm Pharmacol 9: 349–59CrossRefGoogle Scholar
  103. 103.
    Kan RE, Hughes SC, Rosen MA, Kessin C, Preston PG, Lobo EP (1998) Intravenous remifentanil. Placental transfer, maternal and neonatal effects. Anesthesiology 88: 1467–1474CrossRefPubMedGoogle Scholar
  104. 104.
    Kauffman RE, Nelson MV (1992) Effect of age on ibuprofen pharmacokinetics and antipyretic response. J Pediatr 121: 969–973CrossRefPubMedGoogle Scholar
  105. 105.
    Kaufman DW, Kelley JP, Levy M (1991) The drug etiology of agranulocytosis and aplastic anemia. Oxford Univ Press, OxfordGoogle Scholar
  106. 106.
    Kelley MT, Watson PD, Edge JH, Cox S, Mortensen ME (1992) Pharmacokinetics and pharmacodynamics of ibuprofen isomers and acetaminophen in febrile children. Clin Pharmacol Ther 52: 181–189CrossRefPubMedGoogle Scholar
  107. 107.
    Killian A, Davis PJ, Stiller RL, Cicco R, Cook DR, Guthrie RD (1990) Influence of gestational age on pharmacokinetics of alfentanil in neonates. Dev Pharmacol Ther 15: 82–85PubMedGoogle Scholar
  108. 108.
    Koehntop DE, Rodamm JH, Brundage DM, Hegland MG (1986) Pharmacokinetics of fentanyl in neonates. Anesth Analg 65: 227–232CrossRefPubMedGoogle Scholar
  109. 109.
    Konstan MW, Hoppel CL, Chai BL, Davis PB (1991) Ibuprofen in children with cystic fibrosis: pharmacokinetics and adverse effects. J Pediatr 118: 956–964CrossRefPubMedGoogle Scholar
  110. 110.
    Koren G, Crean P, Goresky GV, Klein J, MacLeod SM (1984a) Pharmacokinetics of fentanyl in children with renal disease. Res Commun Chem Pathol Pharmacol 46: 371–379PubMedGoogle Scholar
  111. 111.
    Koren G, Goresky G, Creau P, Klein J, Mac Lerd SM (1984b) Pediatric fentanyl dosing based on pharmacokinetics during cardiac surgery. Anesth Analg 63: 577–582CrossRefPubMedGoogle Scholar
  112. 112.
    Koren G, Butt W, Chinvanga H, Soldin S, Tan YK, Pape K (1985) Post-operative morphine infusion in newborn infants: Assessment of disposition characeteristics and safety. J Pediatr 107: 963–967CrossRefPubMedGoogle Scholar
  113. 113.
    Kornblum HI, Langklin SE, Leslie FM (1987) Effects of morphine on DNA synthesis in neonatal rat brain. Dev Brain Res 31: 45–52CrossRefGoogle Scholar
  114. 114.
    Krane EJ (1988) Delayed respiratory depression in a child after caudal epidural morphine. Anesth Analg 67: 79–82CrossRefPubMedGoogle Scholar
  115. 115.
    Kuhls E, Gauntlett IS, Lau M, Brown R, Rudolph CD, Teitel DF, Fisher DM (1995) Effect of increased intra-abdominal pressure on hepatic extraction and clearance of fentanyl in neonatal lambs. J Pharmacol Exp Ther 274: 115–119PubMedGoogle Scholar
  116. 116.
    Kuhnert BR, Kuhnert PM, Tu A-S, Lin DCK (1979) Meperidine and normeperidine levels following meperidine administration during labor. II Fetus and neonate. Am J Obstet Gynecol 133: 909–914PubMedGoogle Scholar
  117. 117.
    Kuhnert BR, Kuhnert PM, Philipson EH, Syracuse CD (1985) Disposition of meperidine and normeperidine following multiple doses during labor. Am J Obstet Gynecol 151: 410–415PubMedGoogle Scholar
  118. 118.
    Lago P, Benini F, Agosto C, Zacchello F (1998) Randomised controlled trial of low dose fentanyl infusion in preterm infants with hyaline membrane disease. Arch Dis Child 79: 194–197CrossRefGoogle Scholar
  119. 119.
    Lajarrige C, Adafer M, Mouthemy G, Kremp L (1993) Effet du fentanyl sur la ventilation du prématuré. Arch Fr Pédiatr so: 27–24Google Scholar
  120. 120.
    Lambertsen CJ, Wendel H, Longenhagen JB (1961) The separate and combined respiratory effects of chlorpromazine and meperidine in normal men controlled at 46 mmHg alveolar pCO2. J Pharmacol Exp Ther 131: 381–393PubMedGoogle Scholar
  121. 121.
    Lehmann KA, Tenbuhs B, Hoeckle W (1986) Patient-controlled analgesia with piritramid for the treatment of post-operative pain. Acta Anaesthesiol Belg 37: 247–257PubMedGoogle Scholar
  122. 122.
    Lesko SM, Mitchell AA (1995) An assessment of the safety of pediatric ibuprofen. JAMA 273: 929–933CrossRefPubMedGoogle Scholar
  123. 123.
    Levy M, Zylber-Katz E, Rosenkranz B (1995) Clinical pharmacokinetics of dipyrone and its metabolites. Clin Pharmacokinet 28: 216–34CrossRefPubMedGoogle Scholar
  124. 124.
    Lin Y-G, Sussman HH, Benitz WE (1997) Plasma concentrations after rectal administration of acetaminophen in preterm neonates. Paediatr Anaesth 7: 457–459CrossRefPubMedGoogle Scholar
  125. 125.
    Lynn AM, Opheim KE, Tyler DT 1984) Morphine infusion after pediatric cardiac surgery. Crit Care Med 8: 863–866CrossRefGoogle Scholar
  126. 126.
    Lynn AM, Slattery JT (1987) Morphine pharmacokinetics in early infancy. Anesthesiology 66: 136–139CrossRefPubMedGoogle Scholar
  127. 127.
    Lynn AM, Nespeca MK, Opheim KE, Slattery JT (1993) Respiratory effects of intravenous morphine infusions in neonates, infants, and children after cardiac surgery. Anesth Analg 77: 695–701CrossRefPubMedGoogle Scholar
  128. 128.
    Mac Gregor R, Evans D, Sugden D, Gaussen T, Levene M (1998) Outcome at 5 – 6 years of prematurely born children who received morphin as neonates. Arch Dis Child 79: 40–43CrossRefGoogle Scholar
  129. 129.
    Magnani B, Evans R, Hegland UG, Buckley J (1999) Codeine intoxication in the neonate. Pediatrics 104: e75CrossRefGoogle Scholar
  130. 130.
    Makela AL, Lempianen M, Ylijorki H (1981) Ibuprofen levels in serum and synovial fluid. Scand J Rheumatol 39: 15–17CrossRefGoogle Scholar
  131. 131.
    Marlow N, Weindling AM, Cooke RWI (1988) Hazards of analgesia for newborn infants. Arch Dis Child 63: 1293–1298CrossRefPubMedGoogle Scholar
  132. 132.
    Marlow N, Weindling AM, Peer A, Heykants J (1990) Alfentanil pharmacokinetics in preterm infants. Arch Dis Child 65: 349–351CrossRefPubMedGoogle Scholar
  133. 133.
    Marsh DF, Hatch DJ, Fitzgerald M (1997) Opioid systems and the newborn. Br J Anaesthesia 79:787–795CrossRefGoogle Scholar
  134. 134.
    Mather IE (1983) Clinical pharmacokinetics of fentanyl and its new derivatives. Clin Pharmacokinet 8: 422–446CrossRefPubMedGoogle Scholar
  135. 135.
    Mather SJ, Pentrell JM (1995) Postoperative morphine requirements, nausea and vomiting following anaesthesia for tonsillectony. Comparison of intravenous morphine and nonopioid analgesic techniques. Pediatr Anaesth 5: 185–188CrossRefGoogle Scholar
  136. 136.
    Maunuksela E-L, Korpola R, Olkkola KT (1988 a) Double-blind, multiple-dose comparison of buprenorphin and morphine in postoperative pain of children. Br J Anaesth 60: 48–55CrossRefPubMedGoogle Scholar
  137. 137.
    Maunuksela EL, Olkkola KT, Korpela R (1988b) Does prophylactic intravenous infusion of indomethacin improve the management of postoperative pain in children? Can J Anaesth 35: 123–130CrossRefPubMedGoogle Scholar
  138. 138.
    McGraw T, Raborn W, Grace M (1987) Analgesics in pediatric dental surgery. J Dent Child 54: 106–109Google Scholar
  139. 139.
    McRorie TI, Lynn AM, Nespeca MK, Opheim KE, Slattery JT (1992) The maturation of morphine clearance and metabolism. Am J Dis Child 146: 972–976PubMedGoogle Scholar
  140. 140.
    Meistelman C, Saint-Maurice G, Leupaul M, Levron JC, Loose JP, Mac Gee G (1987) A comparison of alfentanil pharmacokinetics in children and adults. Anesthesiology 66: 13–16CrossRefPubMedGoogle Scholar
  141. 141.
    Meistelman C, Benhamou D, Barre J, Levron J-C, Mahe V, Mazoit X, Ecoffey C (1990) Effects of age on plasma protein binding of sufentanil. Anesthesiology 72: 470–473CrossRefPubMedGoogle Scholar
  142. 142.
    Meuldermans WEG, Hurkmans RMA, Heykants J (1982) Plasma protein binding and distribution of fentanyl, sufentanil, alfentanil and lofentanil in blood. Arch Int Pharmacodyn Ther 257: 4–19PubMedGoogle Scholar
  143. 143.
    Meuldermans W, Woestenborghs R, Noorduin H, Camu F, von Steenberge A, Heykants J (1986) Protein binding of the analgesics alfentanil and sufentanil in maternal and neonatal plasma. Eur J Pharmacol 30: 217–219Google Scholar
  144. 144.
    Meuldermans W, Hendrickx J, Lauwers et al. (1987) Excretion and biotransformation of alfentanil and sufentanil in rats and dogs. Drug Metab Dispos 15: 905–913PubMedGoogle Scholar
  145. 145.
    Miller RP, Roberts RJ, Fischer LJ (1976) Acetaminophen elimination kinetics in neonates, children, and adults. Clin Pharmacol Ther 19: 284–294PubMedGoogle Scholar
  146. 146.
    Monk JP, Berenford R, Ward A (1988) Sufentanil: A review of its pharmacologic properties and therapeutic use. Drugs 36: 286–313CrossRefPubMedGoogle Scholar
  147. 147.
    Morselli PL, Roven V (1980) Placental transfer of pethidin and norpethidin and their pharmacokinetics in the newborn. Eur J Clin Pharmacokinet 18: 25–30CrossRefGoogle Scholar
  148. 148.
    Moulenaar F, Schoonen AJM, Evertz A, Huizinga T (1979) Biopharmaceutics of rectal administration of drugs in man. 4: Absorption rate and bioavailability of paracetamol from fatty suppositories. Pharm Week (Sci) 1: 89–94CrossRefGoogle Scholar
  149. 149.
    Murat I, Levon JC, Berg A, Saint-Maurice C (1988) Effects of fentanyl on baroreceptor reflex control of heart rate in newborn infants. Anesthesiology 68 68: 717–722CrossRefPubMedGoogle Scholar
  150. 150.
    Nahata M, Miser A, Miser JS, Reuning RH (1985) Variation in morphine pharmacokinetics in children with cancer. Dev Pharmacol Ther 8: 182–188PubMedGoogle Scholar
  151. 151.
    Nation RL (1981) Meperidine binding in maternal and fetal plasma. Clin Pharmacol Ther 29: 472–479CrossRefPubMedGoogle Scholar
  152. 152.
    Nichols DG, Yaster M, Lynn AM et al. (1993) Disposition and respiratory effect of intrathecal morphine in children. Anesthesiology 79: 733–738CrossRefPubMedGoogle Scholar
  153. 153.
    Olkkola KT, Maunuksela E-L, Korpela R, Rosenberg PH (1988) Kinetics and dynamics of postoperative intravenous morphine in children. Clin Pharmacol Ther 44: 128–136CrossRefPubMedGoogle Scholar
  154. 154.
    Olkkola KT, Maunuksela E-L, Korpela R (1989) Pharmacokinetics of intravenous buprenorphin in children. Br J Pharm 28: 202–204CrossRefGoogle Scholar
  155. 155.
    Olkkola KT, Hamunen K, Seppäla T, Maunuksela EL (1994) Pharmacokinetics and ventilatory effects of intravenous oxycodone in postoperative children. Br J Clin Pharm 38: 71–76CrossRefGoogle Scholar
  156. 156.
    Olkkola KT, Hamunen K, Maunuksela E-L (1995) Clinical pharmacokinetics and pharmacodynamics of opioid analgesics in infants and children. Clin Pharmacokinet 28: 385–404CrossRefPubMedGoogle Scholar
  157. 157.
    Orsini AJ, Leet KH, Costarino A, Dettore MD, Stefano JL (1996) Routine use of fentanyl infusions for pain and stress reduction in infants with respiratory distress syndrome. J Pediatr 129: 140–145CrossRefPubMedGoogle Scholar
  158. 158.
    Osborne RJ, Joel SP, Slevin ML (1986) Morphine intoxication in renal failure: the role of morphine-6-glucuronide. Br J Med 232: 1548–1549CrossRefGoogle Scholar
  159. 159.
    Petrat G, Klein U, Meißner W (1997) On-demand analgesia with piritramide in children A study on dosage specification and safety. Eur J Pediatr Surg 7:38–41 – 41CrossRefPubMedGoogle Scholar
  160. 160.
    Poyhiä R, Seppäla T, Olkkola K, Kalso E (1992) The pharmacokinetics and metabolism of oxycodone after intramuscular and oral administration to healthy subjects. Br J Clin Pharm 33: 617–621CrossRefGoogle Scholar
  161. 161.
    Pokela M-L, Olkkola KT, Koivisto M, Ryhänen P (1992a) Pharmacokinetics and pharmacodynamics of intravenous meperidine in neonates and infants. Clin Pharmacol Ther 52: 342–349CrossRefPubMedGoogle Scholar
  162. 162.
    Pokela M-L, Ryhänen PT, Koivisto ME, Olkkola KT, Sankkonen AL (1992b) Alfentanilinduced rigidity in newborn infants. Anesth Analg 75: 252–257CrossRefPubMedGoogle Scholar
  163. 163.
    Pokela M-L, Olkkola KT, Seppälä T, Koivisto M (1993) Age-related morphine kinetics in infants. Dev Pharmacol Ther 20: 26–34PubMedGoogle Scholar
  164. 164.
    Pokela M-L (1997) Overdoses of pethidin given to preterm neonates. Acta Paediatr 86: 323–325CrossRefPubMedGoogle Scholar
  165. 165.
    Porter FL, Grunau RE, Anand KJS (1999) Long-term effects of pain in infants. Dev Behav Pediatr 20: 253–261CrossRefGoogle Scholar
  166. 166.
    Purcell-Jones G, Dormon MB, Summer BM (1987) The use of opioids in neonates: A retrospective study of 933 cases. Anaesthesia 42: 1316–1320CrossRefPubMedGoogle Scholar
  167. 167.
    Rantiainen P (1991) Alfentanil infusion for sedation in infants and small children during cardiac catherization. Can J Anaesth 38: 980–984CrossRefGoogle Scholar
  168. 168.
    Reyle-Hahn M, Niggemann B, Max M, Streich R, Rossaint R (2000) Remifentanil and propofol for sedation in children and young adolescents undergoing diagnostic flexible bronchoscopy. Paediatr Anesth 10: 59–63CrossRefGoogle Scholar
  169. 169.
    Rita L, Seleny F, Goodarzi M (1980) Comparison of the calming and sedative effects of nalbuphine and pentazocine for paediatric premedication. Can Anaesth Soc 27: 546–549CrossRefGoogle Scholar
  170. 170.
    Rivera-Penera T, Gugig R, Davis J et al. (1997) Outcome of acetaminophen overdose in pediatric patients and factors contributing to hepatotoxicity. J Pediatr 130: 300–304CrossRefPubMedGoogle Scholar
  171. 171.
    Robieux IC, Kellner JD, Coppes MJ et al. (1992) Analgesia in children with sickle cell crisis: Comparison of intermittent opioids vs continuous intravenous infusion of morphine and placebo-controlled study of oxygen inhalation. Pediatr Hematol Oncol 9: 317–326CrossRefPubMedGoogle Scholar
  172. 172.
    Roth B, Schlünder C, Houben F, Günther M, Theisohn M (1991) Analgesia and sedation in neonatal intensive care using fentanyl by continous infusion. Dev Pharmacol Ther 17: 121–127PubMedGoogle Scholar
  173. 173.
    Roure PN, Jean N, Leclerc AC et al. (1987) Pharmacokinetics of alfentanil in children undergoing surgery. Br J Anaesth 59: 1437–1440CrossRefPubMedGoogle Scholar
  174. 174.
    Ryan JP, Meakin G (1989) Fentanyl overdose in a neonate: use of naloxone. Anaesthesia 44: 864–865CrossRefPubMedGoogle Scholar
  175. 175.
    Saarenmaa E, Huttunen P, Leppäluoto J, Fellman V (1996) Alfentanil as procedural pain relief in newborn infants. Arch Dis Child 75: F103–107CrossRefGoogle Scholar
  176. 176.
    Saarenmaa E, Huttunen P, Leppäluoto J, Meretoja O, Fellman V (1999) Advantages of fentanyl over morphine in analgesia for ventilated newborn infants after birth: A randomized trial. J Pediatr 134: 144–150CrossRefPubMedGoogle Scholar
  177. 177.
    Santeiro ML, Christie J, Stromquist C, Torres BA, Markowsky SJ (1997) Pharmacokinetics of continuous infusion of fentanyl in newborns. J Perinatol 17: 135–139PubMedGoogle Scholar
  178. 178.
    Schäffer J, Piepenbrock S, Kretz F-J, Schönfeld C (1986) Nalbuphin und Tramadol zur postoperativen Schmerzbekämpfung bei Kindern. Anaesthesist 35: 408–413PubMedGoogle Scholar
  179. 179.
    Schäffer J, Hagemann H, Holzapfel S, Panning B, Piepenbrock S (1989) Untersuchung zur postoperativen Schmerztherapie bei Kleinkindern mit Tramadol. Fortschritte Anästh Notfall-Intensivmed 3: 42–45Google Scholar
  180. 180.
    Scholz J, Steinfath M, Schulz M (1996) Clinical pharmacokinetics of alfentanil, fentanyl and sufentanil. Clin Pharmacokinet 31: 275–292CrossRefPubMedGoogle Scholar
  181. 181.
    Schwartz AE, Matteo RS, Ornsteine E, Thornhill BA (1987) Pharmacokinetics of sufentanil in hyperventilated patients. Anaesth Analg 66 Suppl: 151CrossRefGoogle Scholar
  182. 182.
    Seguin JH, Erenberg A, Leffl PD (1994) Safety and efficacy of sufentanil therapy in the ventilated Infant. Neonatal Network 13: 37–40PubMedGoogle Scholar
  183. 183.
    Seibert K, Zhang Y, Leahy K et al. (1994) Pharmacological and biochemical demonstration of the role of cyclooxygenase 2 in inflammation and pain. Proc Natl Acad Sci USA 91: 12013–12017CrossRefPubMedGoogle Scholar
  184. 184.
    Semple V, Russell S, Doyle E, Aldridge L M (1999) Comparison of morphine sulphate and codein phosphate in children undergoing adrenotonsillectomy. Paediatr Anaesth 9: 135–138CrossRefPubMedGoogle Scholar
  185. 185.
    Shanahan EC, Marshall AG, Garrett CPO (1983) Adverse reactions of intravenous codeine phosphate in children. Anaesthesia 38: 40–43CrossRefPubMedGoogle Scholar
  186. 186.
    Shah V, Taddio A, Ohlsson A (1998) Randomized controlled trial of paracetamol for heel prick pain in neonates. Arch Dis Child 79: F209–F211CrossRefGoogle Scholar
  187. 187.
    Shann F (1993) Paracetamol: When, why, and how much? J Pediatr Child Health 29: 84–85CrossRefGoogle Scholar
  188. 188.
    Shlugman D, Dufore S, Dershwitz M et al. (1994) Respiratory effects of remifentanil in subjects with severe renal impairment compared to matched controls. Anesthesiology 81, A1417CrossRefGoogle Scholar
  189. 189.
    Singleton MA, Rosen J, Fisher DM (1984) Pharmacokinetics of fentanyl in infants and adults. Anesthesiology 61: A440CrossRefGoogle Scholar
  190. 190.
    Sjögren P, Dragsted L, Christensen CB (1993) Myoclonic spasms during treatment with high doses of intravenous morphine in renal failure. Acta Anaesth Scand 37: 780–782CrossRefPubMedGoogle Scholar
  191. 191.
    Stanski DR, Paalzow L, Edlund PO (1982) Morphine pharmacokinetics: GLC assay versus radioimmunoassay. J Pharm Sci 71: 314–7CrossRefPubMedGoogle Scholar
  192. 192.
    Steans A, Manners PJ, Robinson IG (1990) A multicenter long-term evaluation of the safety and efficacy of ibuprofen syrup in children with juvenile chronic arthritis. BJCP 44: 172–175Google Scholar
  193. 193.
    Stile IL, Fort M, Wurzburger RJ (1987) The pharmacokinetics of naloxone in the premature newborn. Dev Pharmacol Ther 10: 454–459PubMedGoogle Scholar
  194. 194.
    Streisand JB, Hague B, van Vreeswijk HV et al (1987) Oral transmucosal fentanyl premedication in children. Anesth Analg 66: S170CrossRefGoogle Scholar
  195. 195.
    Talbott GA, Lynn AM, Levy FH, Zelikovic I (1997) Respiratory arrest precipitated by codeine in a child with chronic renal failure. Clin Pediatr 36: 171–173CrossRefGoogle Scholar
  196. 196.
    Tegeder I, Lötsch J, Geisslinger G (1999) Pharmacokinetics of opioids in liver disease. Clin Pharmacokinet 37: 17–40CrossRefPubMedGoogle Scholar
  197. 197.
    Tempel A, Habas JE, Paredes W, Barr GA (1988) Morphine induced down regulation of μt-opioid receptors in neonatal rat brain. Dev Brain Res 41: 129–133CrossRefGoogle Scholar
  198. 198.
    Thornton SR, Compton DR, Smith FL (1998) Ontogeny of mu opioid agonist antinociception in postnatal rats. Dev Brain Res 105: 269–276CrossRefGoogle Scholar
  199. 199.
    Tobias JD (1996) Tramadol for postoperative analgesia in adolescents following orthopedic surgery in a third world country. Am J Pain Manage 6: 51–53Google Scholar
  200. 200.
    Tobias JD (1997) Seizure after overdose of tramadol. South Med J 90: 826–827CrossRefPubMedGoogle Scholar
  201. 201.
    Vandenberghe H, Mac Leod S, Chinyanga H, Endrenyi L, Soldin S (1983) Pharmacokinetics of intravenous morphine in balanced anesthesia: Studies in children. Drug Metab Rev 14: 887–903CrossRefPubMedGoogle Scholar
  202. 202.
    Van Lingen R, Quak C, Deinum H, van de Logt F, van Eyck J, Okken A (1995) Clinical effects of rectally administerd acetaminophen (APAP) on infants delivered by vacuumextraction (VE). Pediatr Res 38: 458Google Scholar
  203. 203.
    Van Lingen RA, Deinum JT, Quak JME et al. (1999) Pharmacokinetics and metabolism of rectally administerd paracetamol in preterm neonates. Arch Dis Child 80, F59–63CrossRefGoogle Scholar
  204. 204.
    Varvarigou A, Bardin CL, Beharry K, Chemtob S, Papageorgiou A, Aranda JV (1996) Early ibuprofen administration to prevent patent ductus arteriosus in premature newborn infants. JAMA 275: 539–544CrossRefPubMedGoogle Scholar
  205. 205.
    Vetter TR, Heiner EJ (1994) Intravenous ketorolac as an adjuvant to pediatric patientcontrolled analgesia with morphine. J Clin Anesth 6: 110–115CrossRefPubMedGoogle Scholar
  206. 206.
    Vinik HR, Kissin I (1998) Rapid development of tolerance to analgesia during remifentanil infusion in humans. Anesth Analg 86: 1307–1311PubMedGoogle Scholar
  207. 207.
    Waldvogel HH (1996) Analgetika — Antinozizeptiva — Adjuvanzien. Handbuch für die Schmerzpraxis. Springer, Berlin Heidelberg New York TokioCrossRefGoogle Scholar
  208. 208.
    Wandless JG (1987) A comparison of nalbuphine with morphine for post-orchidopexie pain. Eur J Anaesth 4: 127–132Google Scholar
  209. 209.
    Waterworth TA (1974) Pentazocine (Fortral) as postoperative analgesic in children. Arch Dis Child 49: 488–90CrossRefPubMedGoogle Scholar
  210. 210.
    Watson PD, Galetta G, Braden NJ, Alexander L (1989) Ibuprofen, acetaminophen, and placebo treatment of febrile children. Clin Pharmacol Ther 46: 9–17CrossRefGoogle Scholar
  211. 211.
    Way WL, Costley EC, Way EL (1965) Respiratory sensitivity of the newborn infant to meperidine and morphin. Clin Pharm Ther 6: 454–461Google Scholar
  212. 212.
    Whyte S, Birrell G, Wyllie J (2000) Premedication before intubation in UK neonatal units. Arch Dis Child 82: F38–F41CrossRefGoogle Scholar
  213. 213.
    Wiest DB, Ohning BL, Gorner SS (1991) The disposition of alfentanil in neonates with respiratory distress. Pharmacotherapy 11: 308–311PubMedGoogle Scholar
  214. 214.
    Wilhelm W, Dorscheid E, Schlaich N, Niederprüm P, Deller D (1999) Remifentanil zur Analgosedierung von Intensivpatienten. Anaesthesist 48: 625–629CrossRefPubMedGoogle Scholar
  215. 215.
    Wilson AS, Stiller RL, Davis PJ, Fedel G, Chakravorti S, Israel BA, McGowan FX (1997) Fentanyl and alfentanil plasma protein binding in preterm and term neonates. Anesth Analg 84: 315–318PubMedGoogle Scholar
  216. 216.
    Wolf AR (1999) Pain, nociception and the developing infant. Paediatr Anaesth 9: 7–17CrossRefPubMedGoogle Scholar
  217. 217.
    Wohltmann M, Roth BL, Coscia CJ (1982) Differential postnatal development of mu and delta opiate receptors. Dev Brain Res 3: 679–684CrossRefGoogle Scholar
  218. 218.
    Yaster M (1987) The dose response of fentanyl in neonatal anesthesia. Anesthesiology 66: 433–435CrossRefPubMedGoogle Scholar
  219. 219.
    Yaster M (1987) Analgesia and anesthesia in neonates. J Pediatr 111: 394–396CrossRefPubMedGoogle Scholar
  220. 220.
    Yaster M, Deshpande JK (1988) Management of pediatric pain with opioid analgesics. J Pediatr 113: 421–429CrossRefPubMedGoogle Scholar
  221. 221.
    Zedie N, Amroy DW, Wagner BK, O’Hara DA (1996) Comparison of intranasal midazolam and sufentanil premedication in pediatric outpatients. Clin Pharmacol Ther 59: 341–348CrossRefPubMedGoogle Scholar
  222. 222.
    Zelis R, Mansour EJ, Capone RJ, Mason DT (1974) The cardiovascular effects of morphine: the peripheral capacitance and resistance vessels in human subjects. J Clin Invest 54: 1247–1258CrossRefPubMedGoogle Scholar
  223. 223.
    Zernikow B, Grießinger N, Fengler R (1999) Schmerztherapie in der Kinderonkologie. Monatsschr Kinderheilkd 147: 438–456CrossRefGoogle Scholar
  224. 224.
    Zucker TP, Flesche CW (1993) Unerwünschte Nebenwirkung: Thrombophlebitis unter kontinuierlicher Piritramid-Infusion. Anästhesiol Intensivmed 34: 360Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2001

Authors and Affiliations

  • B. Roth
  • Ch. Hünseler

There are no affiliations available

Personalised recommendations